Sanofi
SNY
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, otā¦ read more
Healthcare
Drug ManufacturersāGeneral
23 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$48.23
Price-0.49%
-$0.23
1Y
Price
Market Cap
$117.492b
Large
Price/Earnings 3y Avg5y Avg
15.7x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in EUR.+32.0%
EBITDA Margin+21.3%
Net Profit Margin-
Free Cash Flow Margin+32.0%
EBITDA Margin+21.3%
Net Profit Margin-
Free Cash Flow MarginRevenue
$42.142b
-4.8%
1y CAGR+1.4%
3y CAGR+1.9%
5y CAGREarnings
$9.113b
+63.9%
1y CAGR+10.5%
3y CAGR+16.5%
5y CAGREPS
$3.85
+75.8%
1y CAGR+15.1%
3y CAGR+18.2%
5y CAGRBook Value
$73.533b
$129.794b
Assets$56.261b
Liabilities$21.755b
DebtDebt to Assets
16.8%
2.3x
Debt to EBITDAFree Cash Flow
$2.093b
-64.4%
1y CAGR-30.8%
3y CAGR-23.6%
5y CAGRNo items found.
Press Releases
Statements and updates from the company